21 May 2013
Keywords: early, synsorb, pk, data, inconclusive, biotech, completed
Article | 18 March 1996
Synsorb Biotech has completed a Phase II/III trial of its treatment for
hemorrhagic colitis, Synsorb Pk, but an initial ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
© 2013 thepharmaletter.com